Crossmark

Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE)

Crossref DOI link: https://doi.org/10.1186/s13063-019-3198-6

Published Online: 2019-01-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Freeman, Daniel https://orcid.org/0000-0002-2541-2197
Lister, Rachel

Waite, Felicity

Yu, Ly-Mee

Slater, Mel

Dunn, Graham

Clark, David
Funding

Funding for this research was provided by:

Medical Research Council (MR/P02629X/1)
License Information

Text and Data Mining valid from 2019-01-29
More Information

Article History

Received: 14 August 2018

Accepted: 15 January 2019

First Online: 29 January 2019

Authors’ information

: Not applicable.

: The trial received a favourable ethical opinion from the NHS Health Research Authority (HRA) South Central – Oxford B Research Ethics Committee (REC reference: 18/SC/0316). Informed written consent will be obtained from all research participants.

: Not applicable.

: DF is a founder and Chief Clinical Officer of Oxford VR, a University of Oxford spinout company (). MS is a founder of Virtual Bodyworks.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below